Valley Medical Pharmacy 
630 Main Street 
Brawley, CA 92227 
eRx ID#0585957 
1 (800) 322-0808 | Toll Free Fax: 1 (855) 322-0808 
Email: drugsdepot@yahoo.com 
Web: www.drugsdepot 
Timing: Monday to Friday | 9:00 AM to 5:45 PM 


Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBB

Image 0 of Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBBImage 1 of Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBBImage 2 of Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBB

Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBB

Call for Price

Zerit 1 mg/ml Powdered Oral Suspension 200 Ml. By BRISTOL-MYERS SQUIBB. Item Number.:RXD2539880/RXB10042758
Size : 200 ML
ABC Selling UoM : EA
NDC: 00003-1968-01
UPC Barcode : 300031968011
Supplier: 0050001077 BRISTOL-MYERS SQUIBB
Supplier Material : 196801
Generic Code : 030250 STAVUDINE ORAL SOLN RECON 1 MG/ML
Fine Line Class : 850085008510 All Rx Products
Product Category : RX Pharmaceuticals
Product Type : BRX Branded RX

Have a question?

  Call for Price

Product Description.:

ZERIT?
(stavudine)

ZERIT?
(stavudine) Capsules

ZERIT?
(stavudine) for Oral Solution

WARNING

LACTIC ACIDOSIS AND SEVERE HEPATOMEGALY WITH STEATOSIS, INCLUDING FATAL CASES, HAVE BEEN REPORTED WITH THE USE OF NUCLEOSIDE ANALOGUES ALONE OR IN COMBINATION, INCLUDING STAVUDINE AND OTHER ANTIRETROVIRALS. FATAL LACTIC ACIDOSIS HAS BEEN REPORTED IN PREGNANT WOMEN WHO RECEIVED THE COMBINATION OF STAVUDINE AND DIDANOSINE WITH OTHER ANTIRETROVIRAL AGENTS. THE COMBINATION OF STAVUDINE AND DIDANOSINE SHOULD BE USED WITH CAUTION DURING PREGNANCY AND IS RECOMMENDED ONLY IF THE POTENTIAL BENEFIT CLEARLY OUTWEIGHS THE POTENTIAL RISK

DESCRIPTION

ZERIT? is the brand name for stavudine (d4T), a synthetic thymidine nucleoside analogue, active against the human immunodeficiency virus (HIV).

ZERIT (stavudine) Capsules are supplied for oral administration in strengths of 15, 20, 30, and 40 mg of stavudine. Each capsule also contains inactive ingredients microcrystalline cellulose, sodium starch glycolate, lactose, and magnesium stearate. The hard gelatin shell consists of gelatin, titanium dioxide, and iron oxides. The capsules are printed with edible inks.

ZERIT (stavudine) for Oral Solution is supplied as a dye-free, fruit-flavored powder in bottles with child-resistant closures providing 200 mL of a 1 mg/mL stavudine solution upon constitution with water per label instructions. The powder for oral solution contains the following inactive ingredients: methylparaben, propylparaben, sodium carboxymethylcellulose, sucrose, and antifoaming and flavoring agents.

INDICATIONS

ZERIT (stavudine), in combination with other antiretroviral agents, is indicated for the treatment of HIV-1 infection (see Clinical Studies).
Clinical Studies
Combination Therapy

The combination use of ZERIT is based on the results of clinical studies in HIV-infected patients in double- and triple-combination regimens with other antiretroviral agents.

One of these studies (START 1) was a multicenter, randomized, open-label study comparing ZERIT (40 mg twice daily) plus lamivudine plus indinavir to zidovudine plus lamivudine plus indinavir in 202 treatment-naive patients. Both regimens resulted in a similar magnitude of inhibition of HIV RNA levels and increases in CD4 cell counts through 48 weeks.
Monotherapy

The efficacy of ZERIT was demonstrated in a randomized, double-blind study (AI455?019, conducted 1992-1994) comparing ZERIT with zidovudine in 822 patients with a spectrum of HIV-related symptoms. The outcome in terms of progression of HIV disease and death was similar for both drugs.